02/09/2021
Between-Batch Bioequivalence (BBE): An Alternative Statistical Method to Assess In Vitro Bioequivalence of Nasal Product INTRODUCTION In the pharmaceutical industry, we can see the development of generics is significantly growing....
Continue Reading
05/06/2021
Nemera is developing and manufacturing complex nasal drug delivery solutions.
Continue Reading
05/06/2021
Nemera’s “RetroNose” concept makes it to On Drug Delivery! The recently published “Pulmonary & Nasal Drug delivery” magazine features Nemera's article: “RETRONOSE: IMPROVING NASAL DELIVERY THROUGH NEW AND IMPROVED ...
Continue Reading
05/06/2021
“Prefilled Syringes & Injection Drug delivery” magazine features Nemera’s article about the importance of device optimization to increase patient safety during self-administration of medication. The recently published “Prefilled syringes &...
Continue Reading
05/06/2021
Nemera’s takes dermal treatments to millions of patients Bioscience Today’s latest issue features Nemera’s article on how we strike the perfect balance of ensuring safety of our ...
Continue Reading
05/06/2021
Nemera is inventing the future of pharma Nemera is the global leader the pharmaceutical and biotechnology industry needs to design, manufacture and sell the drug delivery systems of today and...
Continue Reading